Congruously, flow cytometry and cleaved caspase-3 analysis demonstrated that CMSP enhanced apoptosis in ESCC cells, which was significantly reversed by the co-administration of rapamycin (Fig. 3C and D). The gene discussed is CASP3; the disease is esophageal squamous cell carcinoma.